Calithera Biosciences (STU:2CB0) Dividend Payout Ratio : 0.00 (As of Dec. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Calithera Biosciences Dividend Payout Ratio?

Calithera Biosciences's dividend payout ratio for the months ended in Dec. 2022 was 0.00.

The historical rank and industry rank for Calithera Biosciences's Dividend Payout Ratio or its related term are showing as below:

STU:2CB0's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.445
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-11), the Dividend Yield % of Calithera Biosciences is 0.00%.

Calithera Biosciences's Dividends per Share for the months ended in Dec. 2022 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Calithera Biosciences Dividend Payout Ratio Historical Data

The historical data trend for Calithera Biosciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calithera Biosciences Dividend Payout Ratio Chart

Calithera Biosciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividend Payout Ratio

Get a 7-Day Free Trial

Calithera Biosciences Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Calithera Biosciences's Dividend Payout Ratio

For the Biotechnology subindustry, Calithera Biosciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calithera Biosciences's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calithera Biosciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Calithera Biosciences's Dividend Payout Ratio falls into.

Calithera Biosciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Calithera Biosciences's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0	/	0
	=	N/A

Calithera Biosciences's Dividend Payout Ratio for the quarter that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2022 )	/	EPS without NRI (Q: Dec. 2022 )
	=	0	/	0
	=	N/A

Calithera Biosciences (STU:2CB0) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Calithera Biosciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Calithera Biosciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Calithera Biosciences (STU:2CB0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calithera Biosciences Inc (STU:2CB0) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080

Website

https://www.calithera.com

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Calithera Biosciences (STU:2CB0) Headlines

No Headlines